Personalized Nutrition Market

How big is Personalized Nutrition Market in 2026?

The personalized nutrition market evolved from a 2025 valuation of USD 15.5 billion to USD 17.8 billion in 2026, and is set to achieve USD 72.0 billion by 2036, reflecting a 15.0% CAGR.

Consumer migration from generic off-the-shelf multivitamins toward biomarker-guided daily supplementation is propelling rapid growth across the global personalized nutrition market, which rose from USD 15.5 billion in 2025 toward a 2026 valuation of USD 17.8 billion and attains USD 72.0 billion in 2036 at a 15.0% CAGR. Active custom-dosed supplement packs, powders, and gummies capture 62.4% of offering type demand in 2026 because monthly subscription refills of pre-portioned daily sachets produce far higher customer lifetime value than one-time test kits. This 15.0% expansion rate outpaces the 9.5% CAGR projected for conventional dietary supplements through 2036, as over-the-counter continuous glucose monitors and capillary blood-spot tests give consumers measurable proof of nutrient gaps and keep them subscribed for 90-day retesting. The growth in personalized nutrition consumption is also reflected in workplace wellness programs, where a January 2026 real-life digital intervention study confirmed that personalized nutrition coaching paired with biomarker feedback significantly improved metabolic health scores among participating adults [1]. However, high out-of-pocket prices for multi-omic lab sequencing and strict FDA and EFSA prohibitions on disease-treatment claims restrain mass-market retail uptake, positioning platforms that bundle affordable blood-spot panels with HSA/FSA-eligible supplement subscriptions to capture the largest buyer share.

Key Market Trends & Insights

• By offering type: Active Custom-Dosed Supplement Packs, Powders & Gummies are projected to capture 62.4% in 2026 because monthly consumable sachets generate recurring subscription orders after initial testing.
• By diagnostic input modality: Blood Biomarker + Continuous Glucose Telemetry is estimated to command 48.3% in 2026 as over-the-counter glucose biosensors pair with dried-blood-spot lipid and vitamin panels.
• By health goal: Metabolic Health, GLP-1 Muscle Preservation & Weight Control is expected to concentrate 42.1% in 2026 owing to high-protein and micronutrient companion protocols for weight-loss patients.
• By business model: Monthly Recurring D2C Supplement & Retest Subscriptions are forecast to generate 67.7% in 2026 through automated 30-day supplement refills and 90-day biomarker re-evaluations.
• By patient demographic: Adult Population 18 to 64 Years is anticipated to account for 52.2% in 2026 driven by corporate wellness stipends and proactive cardiometabolic optimization.

Regional Highlights

• Leading national expansion: South Korea is projected to lead covered national markets at a 16.8% CAGR through 2036 under regulatory sandboxes permitting retail custom supplement dispensing.
• Broader country progression: The United Arab Emirates is expected to expand at a 16.4% CAGR ahead of the United States at 14.2% and the United Kingdom at 13.8%, while Germany records 13.5%.

Market Size & Forecast

Table 1: Market Size and Forecast for the Personalized Nutrition Market (USD billion and CAGR percentage), 2025 to 2036

Metric	Value
2025 Market Size	USD 15.5 billion
Estimated Market Size in 2026	USD 17.8 billion
Projected Market Size by 2036	USD 72.0 billion
CAGR, 2026 to 2036	15.0%
Added Valuation, 2026 to 2036	USD 54.2 billion

Wider availability of over-the-counter continuous glucose biosensors and home capillary blood-collection kits is changing how health-conscious consumers purchase daily vitamins and protein powders. Instead of guessing which supplements to take, buyers can view real-time blood-sugar curves on their smartphones and order custom-blended daily packets tailored to their metabolic readings. For instance, a July 2026 randomized clinical trial from Jeonbuk National University showed that continuous glucose monitoring-guided personalized nutrition significantly reduced glycemic spikes and improved dietary adherence in adults [2]. In addition to this, nutrition brands that link continuous glucose monitoring systems directly to automated monthly supplement pouch adjustments record stronger 12-month subscriber retention.

Subscriber-Cohort and Diagnostic-Kit Sizing

Table 2: Subscriber-Cohort and Diagnostic-Kit Sizing for the Personalized Nutrition Market (USD billion and operational ranges), 2025 to 2036

Metric	2025	2026	2036
Market size (USD billion)	15.5	17.8	72.0
Active D2C & clinic subscribers (billion)	0.024 to 0.028	0.028 to 0.032	0.105 to 0.120
Annual biomarker & microbiome kits (billion)	0.035 to 0.042	0.040 to 0.048	0.150 to 0.175
Annual spend per subscriber (USD)	550.0 to 645.0	555.0 to 635.0	600.0 to 685.0

Operational note: Subscriber and diagnostic kit ranges reflect active monthly direct-to-consumer supplement memberships, longevity clinic cohorts, and quarterly blood, CGM, and microbiome test volumes.

Subscription unit economics in the personalized nutrition sector depend on keeping monthly pouch cancellation rates low enough to recover the initial cost of subsidized diagnostic test kits and customer acquisition ads. Companies that combine nutrigenomic testing panels with quarterly dried-blood-spot retests show subscribers visible improvements in vitamin D and lipid levels, which supports long-term subscription renewals.

Per Capita & Longevity Clinic Sizing

Table 3: Per Capita and Clinic Valuation Indicators for the Personalized Nutrition Market (USD), 2025 to 2036

Metric	2025	2026	2036
World population (billion)	8.2	8.3	9.0
Valuation per 1,000 people (USD)	1,890.2	2,144.6	8,000.0
Annual spend per longevity clinic (USD thousand)	320.0 to 380.0	350.0 to 410.0	680.0 to 790.0
Recurring subscription auto-ship share (%)	65.0% to 68.0%	66.0% to 70.0%	74.0% to 78.0%

Table 4: Clinic & Subscriber Valuation Indicators for the Personalized Nutrition Market (USD and percentages), 2026

Metric	Value	Institutional Reference Basis
Market size, 2026	USD 17.8 billion	2026 global valuation baseline
Partner wellness & longevity clinics	46.0 thousand	Global integrative nutrition & wellness clinic registry
Market value per clinic	USD 387.0 thousand	Annualized biomarker kit and custom supplement spend
Custom supplement packs value, 2026	USD 11.1 billion	62.4% offering type segment allocation

Widespread adoption of GLP-1 weight-loss therapies has created a fast-growing buyer group that requires high-bioavailability protein and micronutrient formulas to prevent lean muscle loss during caloric restriction. Formulators are introducing compact miniprotein supplement blends, prebiotic fibers, and electrolyte sachets designed specifically for smaller daily meal volumes.

Analyst Perspective

"Standalone DNA or microbiome test kits that deliver a one-time PDF food list fail to build durable commercial value. Brands that convert continuous glucose telemetry and quarterly blood-spot panels into automated 30-day custom supplement packs and GLP-1 muscle-preservation subscriptions will capture the highest lifetime customer value through 2036."

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights.

How is the Personalized Nutrition Market Segmented?

The personalized nutrition market is segmented by offering type, diagnostic input modality, health goal, business model, and patient demographic. In 2026, Active Custom-Dosed Supplement Packs, Powders & Gummies is projected at 62.4%, Blood Biomarker + Continuous Glucose Telemetry at 48.3%, Metabolic Health, GLP-1 Muscle Preservation & Weight Control at 42.1%, Monthly Recurring D2C Supplement & Retest Subscriptions at 67.7%, and Adult Population 18 to 64 Years at 52.2%.

By diagnostic input modality: Blood Biomarker + Continuous Glucose Telemetry, 16S & Shotgun Metagenomic Gut Microbiome Sequencing, and Nutrigenomic SNP Profiling & Algorithmic Questionnaires.

By health goal: Metabolic Health, GLP-1 Muscle Preservation & Weight Control, Longevity, Cellular NAD+ & Cognitive Optimization, and Athletic Performance, Recovery & Gut Immunity.

By business model: Monthly Recurring D2C Supplement & Retest Subscriptions and Corporate Wellness, Payer & Longevity-Clinic B2B2C. By patient demographic: Adult Population 18 to 64 Years, Geriatric Population 65 Years and Older, and Pediatric and Adolescent Patients.

By patient demographic: Adult Population 18 to 64 Years, Geriatric Population 65 Years and Older, and Pediatric and Adolescent Patients (with Private Commercial Health Insurance and Out-of-Pocket at 56.3% and Prescription and Clinician-Supervised at 54.5%).

Why do active custom-dosed supplement packs lead the offering type category?

Within offering type, active custom-dosed supplement packs, powders & gummies are anticipated to maintain the leading position with 62.4% share in 2026, driven by daily sachet replenishment.

Table 5: Offering Type Share for the Personalized Nutrition Market (percentage share), 2026

Offering Type	Share (2026)
Active Custom-Dosed Supplement Packs, Powders & Gummies	62.4%
Other Segments Combined	37.6%*
Total	100.0%

*Note: Remaining offering type categories sum to 100.0% of 2026 personalized nutrition market valuation.

Table 6: Offering Type Leadership and Market Growth for the Personalized Nutrition Market (segment and CAGR percentage), 2026 to 2036

Metric	Value
Global CAGR (2026 to 2036)	15.0%
Leading Segment	Active Custom-Dosed Supplement Packs, Powders & Gummies

While home diagnostic test kits bring new customers into the brand funnel, consumable daily supplement packs and pectin gummies generate 62.4% of category valuation through recurring monthly auto-shipments. High-speed automated pouch lines pack personalized morning and evening combinations of probiotic ingredient blends, chelated minerals, and omega-3 softgels printed with each customer's name.

• Within offering type, active custom-dosed supplement packs, powders & gummies are anticipated to maintain the leading position with 62.4% share in 2026, driven by monthly consumable replenishment.
• Biomarker testing kits and AI mobile nutrition apps form the diagnostic engine that guides formulation adjustments across every subscriber cohort. A September 2025 randomized trial comparing continuous glucose monitoring against standard fingerstick testing confirmed that real-time sensor feedback produced superior dietary compliance and glycemic control in carbohydrate-restricted diets [3]. By showing users how specific meals and supplements affect their daily glucose and lipid scores, diagnostic apps drive higher attachment rates for companion supplement subscriptions.

What supports blood biomarker + continuous glucose telemetry in diagnostic input modality?

By diagnostic input modality, blood biomarker + continuous glucose telemetry is estimated to hold 48.3% in 2026, supported by quantitative HbA1c, lipid, and postprandial glucose tracking.

Blood biomarker panels paired with continuous glucose telemetry lead diagnostic input demand because blood levels of vitamin D, ferritin, and HbA1c change measurably within 8 to 12 weeks of starting a supplement regimen. Capillary blood-spot cards paired with digestive health supplements allow subscribers to confirm objective biomarker gains on their quarterly follow-up test.

• By diagnostic input modality, blood biomarker + continuous glucose telemetry is estimated to hold 48.3% in 2026, owing to actionable 90-day biomarker retesting.
• Gut microbiome sequencing and nutrigenomic single-nucleotide polymorphism (SNP) panels complement blood assays by identifying how an individual metabolizes dietary fats, folate, and fermentable fibers. In September 2025, a comprehensive review in Food Science & Nutrition confirmed that integrating digital health wearables with microbiome and genetic profiling improved long-term dietary personalization and metabolic outcomes [4]. Lower laboratory sequencing costs now allow subscription brands to bundle baseline DNA and stool microbiome reports into annual wellness memberships.

How is metabolic health, GLP-1 muscle preservation & weight control gaining use by health goal?

Based on health goal, metabolic health, GLP-1 muscle preservation & weight control is projected to account for 42.1% in 2026, owing to amino acid and fiber fortification during incretin therapy.

Metabolic health, weight control, and GLP-1 muscle preservation represent the largest health goal segment as millions of adults seek nutritional support to maintain lean muscle mass and energy levels during weight reduction. Manufacturers formulate leucine-enriched protein supplements, soluble fibers, and bioavailable multivitamins to address nutrient gaps caused by reduced food intake.

• Based on health goal, metabolic health, GLP-1 muscle preservation & weight control is projected to account for 42.1% in 2026, supported by companion protocols for weight-loss therapies.
• Corporate wellness programs and health insurers are also adopting telehealth-delivered personalized nutrition to lower long-term medical claims for type 2 diabetes and hypertension. According to an August 2026 health-economic study, telehealth-delivered personalized nutrition interventions significantly reduced outpatient healthcare costs and cardiometabolic medication needs among high-risk adults [5]. Meanwhile, athletic performance and cellular longevity segments attract high-income buyers purchasing NAD+ precursors and targeted gut synbiotics.

Why do monthly recurring D2C supplement & retest subscriptions lead by business model?

In 2026, monthly recurring D2C supplement & retest subscriptions are expected to lead business model with 67.7% share, enabled by 30-day auto-ship packs and 90-day biomarker retesting.

Monthly recurring direct-to-consumer supplement and retest subscriptions capture two-thirds of market demand because automated 30-day pouch deliveries remove the hassle of buying multiple separate vitamin bottles at retail stores. Subscription platforms use mobile app check-ins and 90-day biomarker retests to adjust milligram dosages as a customer's blood levels normalize.

• In 2026, monthly recurring D2C supplement & retest subscriptions are expected to lead business model with 67.7% share, enabled by automated 30-day sachet fulfillment.
• Corporate wellness portals, longevity clinics, and B2B2C health plans represent the fastest-growing business model as employers and concierge physicians bundle biomarker panels with personalized nutraceutical regimens. In August 2025, a precision medicine study confirmed that combining digital health coaching with individualized metabolic profiling improved long-term patient adherence across chronic care cohorts [6]. Broader HSA and FSA tax-advantaged account eligibility further lowers out-of-pocket costs for employees enrolling in B2B2C nutrition programs.

Which market conditions keep adult population 18 to 64 years ahead by patient demographic?

By patient demographic, adult population 18 to 64 years is forecast to represent 52.2% in 2026, reinforced by corporate wellness subsidies and preventive longevity adoption.

Adults aged 18 to 64 years account for 52.2% of demographic demand because working-age consumers are the primary adopters of wearable glucose sensors, athletic recovery powders, and metabolic weight-management subscriptions. Private commercial health insurance and out-of-pocket payments represent 56.3% of category funding with clinician-supervised protocols at 54.5% share, while geriatric cohorts aged 65 and older expand through physician-guided protein and bone-health sachets.

• By patient demographic, adult population 18 to 64 years is forecast to represent 52.2% in 2026, linked to out-of-pocket wellness outlays and corporate health stipends.
• Pediatric and specialized clinical nutrition segments also rely on dietitian-supervised digital platforms to manage inherited metabolic disorders, food allergies, and gastrointestinal absorption conditions. In March 2025, dsm-firmenich highlighted five breakthrough gut-health trends from the Probiota congress, emphasizing precision prebiotics and microbiome-targeted formulations for individualized digestive care [8]. Clinician dashboards now allow registered dietitians to review patient food logs and adjust daily supplement formulas remotely.

What are the drivers, restraints, and opportunities in the personalized nutrition market?

In the personalized nutrition market, the key driver is GLP-1 metabolic muscle preservation and CGM feedback, the key restraint is subscription churn from high out-of-pocket retest costs, and the key opportunity is microbiome-guided synbiotic formulation.

• Driver: Widespread adoption of over-the-counter continuous glucose biosensors and GLP-1 weight-loss therapies drives consumer demand for biomarker-calibrated protein, fiber, and micronutrient subscriptions.
• Restraint: High out-of-pocket costs for shotgun metagenomic sequencing and quarterly blood panels combined with data-privacy concerns trigger subscription fatigue among price-sensitive shoppers.
• Opportunity: Pairing 16S and shotgun gut-microbiome sequencing with precision prebiotic, probiotic, and postbiotic sachets opens high-margin synbiotic subscriptions across longevity clinics.

Growth Analysis and Future Potential: Qualitative Demand Catalysts

Rapid consumer adoption of over-the-counter continuous glucose monitors and at-home blood-fingerstick cards is a primary driver converting casual vitamin buyers into long-term personalized nutrition subscribers. When consumers can see how their morning meal or workout affects real-time blood sugar and quarterly lipid markers, they are far more willing to pay for customized daily supplement packets. For instance, a December 2025 randomized controlled trial demonstrated that real-time continuous glucose monitoring paired with individualized dietary guidance significantly improved glycemic control and weight outcomes compared with standard care [9]. Based on FMI analysis, brands that link these diagnostic readings directly to high-bioavailability nutraceuticals such as liposomal vitamins and spore-forming probiotics achieve stronger subscription retention.

Risk Assessment of the Personalized Nutrition Market: Subscription Churn and Assay Cost Friction

On the other hand, high out-of-pocket prices for multi-omic lab kits and methodological differences between commercial microbiome laboratories remain key factors restraining mass-market adoption. Comprehensive shotgun metagenomic stool sequencing and multi-marker blood panels often cost USD 150 to USD 400 upfront, which discourages price-sensitive retail shoppers before monthly supplement deliveries even begin. A January 2026 review on metabolic disease mitigation through nutrigenomics and microbiome profiling noted that standardizing reference databases and clinical interpretation thresholds remains necessary for consistent dietary recommendations[10]. In addition to lab costs, strict FDA and EFSA structure-function rules bar supplement brands from making disease-treatment claims around medical foods without clinical trial dossiers.

Commercial Opportunity Analysis: Longevity NAD+ Optimization and Microbiome Synbiotics

Rapid expansion of GLP-1 weight-loss prescriptions and preventative longevity clinics is creating a major commercial opportunity for targeted muscle-preservation and cellular-health nutrition packages. Patients using incretin weight-loss medications experience reduced appetite that can lead to protein, iron, and vitamin B12 shortfalls unless they consume nutrient-dense daily formulations. In April 2026, a life-course personalized nutrition study in Nutrition Research and Practice confirmed that tailoring protein and micronutrient intake to age and metabolic profile significantly improved diet quality and muscle health [11]. Ingredient suppliers are now partnering with clinical nutrition brands to launch compact whey-microgel shakes, collagen peptides, and gut-barrier synbiotics tailored for weight-management patients.

Personalized Nutrition Market by Country (2026 to 2036)

In the FMI report, South Korea and the United Arab Emirates lead national personalized nutrition expansion at 16.8% and 16.4% CAGR through 2036, followed by the United States (14.2%), the United Kingdom (13.8%), Germany (13.5%), Canada (13.1%), France (12.8%), and Australia (12.5%). Dedicated customized health functional food legislation and concierge longevity clinics propel Asian and Gulf growth, whereas North America and European markets scale through OTC glucose biosensors and GLP-1 companion nutrition.

Table 7: Country CAGR and Primary Growth Levers for the Personalized Nutrition Market (CAGR percentage and operational drivers), 2026 to 2036

Country	CAGR (2026 to 2036)	Primary Growth Lever
South Korea	16.8%	Ministry of Food and Drug Safety customized health functional food dispensing sandboxes
United Arab Emirates	16.4%	Dubai longevity clinic buildouts and preventive genomic-metabolic wellness programs
United States	14.2%	OTC continuous glucose biosensor launches and GLP-1 muscle-preservation supplement subscriptions
United Kingdom	13.8%	Large-scale gut microbiome and postprandial blood-fat home testing subscription platforms
Germany	13.5%	Pharmacy-led micronutrient blood-spot screening and clean-label vegan supplement compliance
Canada	13.1%	Licensed naturopathic and preventive longevity clinic biomarker subscription programs
France	12.8%	Pharmacie-dispensed individualized probiotic and micronutrient compounding protocols
Australia	12.5%	TGA-listed practitioner-dispensed custom nutraceutical and sports biomarker subscriptions

Source: Future Market Insights analysis

South Korea Personalized Nutrition Market Outlook (2026 to 2036)

South Korea leads global growth following the Ministry of Food and Drug Safety (MFDS) regulatory institutionalization of Customized Health Functional Foods, which legally permits pharmacists and certified nutritionists to subdivide bulk tablets into individualized 30-day daily sachets based on consumer biomarker results. South Korea's personalized nutrition valuation is forecast to surge at a 16.8% CAGR through 2036, propelled by pharmacy-dispensed custom packs and AI mobile diet coaching. An October 2025 randomized trial in a medical internet research journal confirmed that mobile app-guided diet coaching paired with continuous glucose telemetry improved glycemic and weight outcomes in overweight adults in Seoul [1]. Domestic leaders Cosmax NBT and Kolmar BNH operate automated small-batch sachet lines for retail chains.

Key takeaway: In South Korea, statutory MFDS customized health functional food dispensing rules and mobile biomarker integration are projected to drive a 16.8% CAGR through 2036.

United Arab Emirates Personalized Nutrition Market Outlook (2026 to 2036)

High prevalence of adult type 2 diabetes and metabolic syndrome combined with rapid government and private investment in preventative longevity medicine position the United Arab Emirates at the forefront of Middle Eastern adoption. Within the United Arab Emirates, personalized nutrition market value is slated for 16.4% CAGR during the forecast decade, reinforced by Abu Dhabi DoH and Dubai DHA precision wellness initiatives. A January 2026 clinical cohort study in Nutrients analyzing Gulf adults demonstrated that biomarker-guided vitamin D3, omega-3, and trace-mineral correction significantly improved insulin sensitivity and lipid profiles [12]. Concierge clinics in Dubai Healthcare City bundle genome sequencing with custom oral nutraceuticals for preventative metabolic care.

Key takeaway: In the United Arab Emirates, concierge longevity clinics and national preventive metabolic screening programs are anticipated to sustain a 16.4% CAGR through 2036.

United States Personalized Nutrition Market Outlook (2026 to 2036)

FDA clearance of over-the-counter continuous glucose biosensors (Dexcom Stelo and Abbott Lingo) and surging demand for GLP-1 companion muscle-preservation nutrition make the United States the largest national personalized nutrition market. In the United States, personalized nutrition industry size will advance at 14.2% CAGR through 2036, supported by corporate HSA/FSA reimbursement eligibility and recurring at-home capillary blood biomarker subscriptions across metropolitan clinics. In July 2025, point-of-care biosensor investigators published validation data in Sensors for a smartphone-connected electrochemical blood and saliva beta-hydroxybutyrate sensor that enables rapid home metabolic tracking [13]. With over 15,000,000 adults prescribed incretin therapies, retail and D2C brands scale customized protein and daily bioavailable micronutrient packs across national retail pharmacies.

Key takeaway: In the United States, OTC glucose biosensor adoption and GLP-1 companion muscle-preservation subscriptions are forecast to generate a 14.2% CAGR through 2036.

United Kingdom Personalized Nutrition Market Outlook (2026 to 2036)

Large-scale direct-to-consumer cardiometabolic and gut-microbiome testing platforms led by King's College London spin-outs and high-street pharmacy chains anchor personalized nutrition demand across the United Kingdom. The United Kingdom personalized nutrition market is anticipated to climb at a 13.8% CAGR to 2036, propelled by home blood-lipid fingerstick kits and shotgun gut-microbiome sequencing across urban households. Precision nutrition platforms pair at-home microbiome sequencing and continuous glucose monitoring with personalized food scoring to guide cardiometabolic risk management [14]. Retail pharmacy partnerships across Boots and Holland & Barrett expand consumer access to hormone and vitamin blood-spot testing. Diagnostic subscription providers integrate registered nutritional therapists to interpret lab panels and boost long-term supplement reorder adherence.

Key takeaway: In the United Kingdom, microbiome-and-CGM home test subscriptions and pharmacy wellness partnerships are estimated to drive a 13.8% CAGR through 2036.

Germany Personalized Nutrition Market Outlook (2026 to 2036)

Germany's personalized nutrition market is shaped by strong consumer preference in Germany for pharmacy-grade micronutrients, plant-based dietary patterns, and clinically validated capillary blood-spot diagnostics. Across Germany, personalized nutrition demand will achieve 13.5% CAGR during the 2026 to 2036 period, driven by targeted micronutrient optimization for vegan and masters-athlete consumer cohorts. A July 2026 study from the University of Vienna and Austrian Agency for Health and Food Safety in Frontiers in Nutrition (VedieS study) analyzing cohorts across Germany and Austria confirmed high reliance on targeted vitamin B12, iron, and iodine biomarker monitoring among plant-based consumers [15]. Strict EU EFSA Health Claims Regulation compliance favors diagnostic-backed supplement brands across retail pharmacies.

Key takeaway: In Germany, pharmacy-verified blood-spot micronutrient testing and vegan-tailored supplement subscriptions are projected to support a 13.5% CAGR through 2036.

Canada Personalized Nutrition Market Outlook (2026 to 2036)

Health Canada's Natural Health Product (NHP) licensing framework and widespread private extended-health benefit accounts support steady adoption of biomarker-guided supplementation across Ontario, Alberta, and Quebec. Canada's personalized nutrition sector will register 13.1% CAGR to 2036, underpinned by naturopathic and dietitian-guided blood biomarker panels and winter vitamin D3 optimization across major metropolitan health and wellness clinics. A February 2026 clinical study in a physiology and nutrition research journal confirmed that individualized vitamin D, iron, and omega-3 dosing guided by dried-blood-spot assays corrected seasonal deficiencies in northern latitudes [16]. Bilingual D2C subscription apps and pharmacy compounding hubs benefit from duty-free regional supply chains and licensed naturopathic practitioner referral networks.

Key takeaway: In Canada, practitioner-guided natural health product subscriptions and employer wellness stipends are predicted to sustain a 13.1% CAGR through 2036.

France Personalized Nutrition Market Outlook (2026 to 2036)

Consumers in France traditionally purchase dietary supplements and dermocosmetic nutricosmetics through neighborhood pharmacies (officines) under licensed pharmacist consultation, while national bioethics statutes in France prohibit direct-to-consumer recreational genetic testing. Because recreational DNA kits are banned, the personalized nutrition sector in France will grow at 12.8% CAGR to 2036 via AI pharmacy questionnaires and blood micronutrient panels across urban pharmacies. An August 2026 clinical study in clinical nutrition research journal demonstrated that food, glucose, sleep, and microbiome data quantifiably personalize postprandial responses across adult cohorts[17]. Prominent dermo-nutrition laboratories in Paris and Lyon formulate personalized skin, hair, and gut-barrier daily ampoule subscriptions for pharmacy and dermatology clinic clients.

Key takeaway: In France, bioethics bans on recreational DNA kits channel 12.8% CAGR personalized nutrition growth into pharmacy-dispensed blood and microbiome regimens.

Australia Personalized Nutrition Market Outlook (2026 to 2036)

Australia combines a high-outlay sports and active-lifestyle consumer base with Therapeutic Goods Administration (TGA) Listed Medicine standards that enable pharmacist- and dietitian-supervised personalized compounding across major urban health clinics. In Australia, personalized nutrition market valuation is expected to register 12.5% compound annual expansion through 2036, aided by practitioner-only clinical nutraceutical dispensing and athletic blood-spot mineral testing across major metropolitan clinics in Sydney and Melbourne. An August 2026 review in Nutrients validated that biomarker-tailored magnesium, iron, and collagen supplementation reduced soft-tissue injury recovery time in endurance athletes [18]. High e-commerce penetration and Asia-Pacific export links attract international D2C supplement brands and clinical sports nutrition formulators across major metropolitan fitness and wellness corridors in Australia.

Key takeaway: In Australia, TGA-regulated practitioner compounding and athletic biomarker-guided recovery subscriptions are forecast to sustain a 12.5% CAGR through 2036.

Full report country CAGRs cover: North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa.

Who are the notable companies in the personalized nutrition market?

DSM-Firmenich AG, Nestlé Health Science S.A., Thorne HealthTech, Inc., ZOE Limited, Viome Life Sciences, Inc., Segterra, Inc., Gainful Health Inc., and Baze Labs (Nature's Way) are the notable companies in the personalized nutrition market.

FMI data suggests that the competitive market structure divides between multinational nutritional ingredient and medical-nutrition conglomerates, science-led diagnostic-and-microbiome platforms, and direct-to-consumer custom supplement brands. Upstream leaders DSM-Firmenich AG and Nestlé Health Science S.A. supply clinically validated vitamin premixes, human milk oligosaccharides, whey microgels, and commercial D2C brands. Diagnostic-first platforms including ZOE Limited, Viome Life Sciences, Inc., and Segterra, Inc. (InsideTracker) monetize proprietary microbiome and blood-biomarker AI databases, while Thorne HealthTech, Inc., Gainful Health Inc., and Baze Labs scale automated custom supplement fulfillment.

• Global Nutritional Premix & Medical Nutrition Leaders: DSM-Firmenich AG and Nestlé Health Science S.A. formulate bioactive vitamin premixes, precision prebiotics, and GLP-1 companion protein and micronutrient portfolios.
• Biomarker, CGM & Microbiome AI Platforms: ZOE Limited, Viome Life Sciences, Inc., and Segterra, Inc. (InsideTracker) combine at-home metagenomic RNA/DNA sequencing, blood panels, and continuous glucose telemetry with algorithmic food and supplement scoring.
• Custom-Dosed D2C Supplement & Sports Specialists: Thorne HealthTech, Inc., Gainful Health Inc., and Baze Labs (Nature's Way) deliver NSF-certified personalized supplement packs, custom protein powders, and capillary blood-guided vitamin sachets.

Competitive Benchmarking: Personalized Nutrition Market

Table 8: Competitive Benchmarking for the Personalized Nutrition Market (qualitative capability ratings), 2026

Company	Custom Formulation & Ingredient Breadth	Biomarker & Microbiome AI Depth	D2C & Clinic Subscription Reach	Geographic Reach
DSM-Firmenich AG	High	High	Medium	High
Nestlé Health Science S.A.	High	Medium	High	High
Thorne HealthTech, Inc.	High	High	High	High
ZOE Limited	Medium	High	High	Medium
Viome Life Sciences, Inc.	Medium	High	High	Medium
Segterra, Inc.	Low	High	High	Medium
Gainful Health Inc.	High	Medium	High	Medium
Baze Labs (Nature's Way)	High	High	Medium	Medium

Scoring basis: Capability ratings evaluate documented clinical trial validation, proprietary blood and microbiome dataset scale, automated single-serve sachet and powder manufacturing capacity, and multi-region D2C and B2B2C distribution.

Key Developments in the Personalized Nutrition Market

• In February 2026, dsm-firmenich published its 2025 Integrated Annual Report detailing expanded science and venture investments across precision gut-microbiome modulation and patient-centric medical nutrition [19]. Through its Hologram Sciences and B2B custom premix platforms, dsm-firmenich supplies diagnostic-linked ingredient systems to global consumer health brands.
• In February 2026, Nestle S.A. announced full-year 2025 results and integrated its Nutrition and Nestle Health Science divisions into a single business unit to accelerate personalized metabolic, GLP-1 companion, and active nutrition leadership [20].
• In August 2026, Thorne HealthTech, Inc. released clinical consumer research supporting its Creatine plus Alpha-GPC personalized performance formula, reporting that 83% of participants experienced improved energy and 80% reported sharper mental focus during exercise [21]. Thorne pairs these NSF Certified for Sport powders with at-home biological-age, gut-health, and heavy-metal testing panels.

Key Players in the Personalized Nutrition Market

Global Nutritional Premix and Medical Nutrition Leaders

• DSM-Firmenich AG
• Nestlé Health Science S.A.
• Biomarker, CGM and Microbiome AI Platforms

ZOE Limited

• Viome Life Sciences, Inc.
• Segterra, Inc.
• Custom-Dosed D2C Supplement and Sports Specialists

Thorne HealthTech, Inc.

• Gainful Health Inc.
• Baze Labs (Nature's Way)

Personalized Nutrition Market - Report Scope

Table 9: Report Scope for the Personalized Nutrition Market (coverage fields and definitions), 2026 to 2036

Coverage field	Report scope
Market breakdown	Offering Type; Diagnostic Input Modality; Health Goal; Business Model; Patient Demographic; Reimbursement Pathway; Regulatory Classification
Quantitative Units	USD Billion
Market Definition	Includes commercial commercial demand of active custom-dosed supplement packs, powders, and gummies with at-home and clinic-administered biomarker testing kits (dried blood spot, continuous glucose telemetry, 16S and shotgun gut microbiome sequencing, nutrigenomic SNP panels, and algorithmic nutrition apps). Category Scope Note: Excludes unpersonalized mass-retail multivitamins and standard hospital parenteral nutrition.
Regions Covered	North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa
Countries Covered	South Korea, United Arab Emirates, United States, United Kingdom, Germany, Canada, France, Australia, and additional countries in the full report
Key Companies Covered	DSM-Firmenich AG, Nestlé Health Science S.A., Thorne HealthTech, Inc., ZOE Limited, Viome Life Sciences, Inc., Segterra, Inc., Gainful Health Inc., Baze Labs (Nature's Way)
Forecast Period	2026 to 2036
Approach	Primary and secondary research with top-down and bottom-up market triangulation.

Personalized Nutrition Market - Research Methodology

Table 10: Research Methodology for the Personalized Nutrition Market (research methods and approach), 2026 edition

Method	Approach
Primary Research	Structured interviews with D2C personalized supplement formulators, longevity clinic medical directors, microbiome sequencing lab executives, and sports dietitians to validate subscriber retention and kit-to-supplement conversion rates.
Secondary Research	Analysis of corporate annual reports, PubMed and PMC randomized controlled trials on CGM-guided and microbiome-tailored nutrition, and national functional food regulatory filings.
Market Sizing and Forecasting	Top-down preventive nutrition and diagnostic kit expenditure models reconciled against bottom-up active monthly D2C subscriber cohorts and 90-day retest volumes from 2026 to 2036.
Country Forecasting Model	Econometric national projections weight adult preventive wellness outlays, GLP-1 prescription companionship rates, and regulatory allowances for custom supplement pack dispensing across eight countries.
Operational Benchmark Traceability	Subscriber cohort and clinic outlays indicators in Tables 2, 3, and 4 trace to JMIR remote randomized trials, South Korea CGM coaching studies, and ZOE PREDICT cardiometabolic cohorts.
Data Triangulation and Validation	Demand estimates are cross-checked against premix ingredient supplier volumes and D2C subscription fulfillment disclosures without double counting commodity retail vitamins.

Personalized Nutrition Market by Segments

Personalized Nutrition Market segmented by Offering Type:

• Active Custom Supplement Packs
• Biomarker Testing Kits
• Algorithmic Coaching Apps

Personalized Nutrition Market segmented by Diagnostic Input Modality:

• Blood Biomarker & CGM
• Gut Microbiome Sequencing
• Nutrigenomic SNP Profiling

Personalized Nutrition Market segmented by Health Goal:

• Metabolic & GLP-1 Support
• Longevity & Cellular NAD+
• Athletic Performance & Recovery
• Gut Immunity & Digestion

Personalized Nutrition Market segmented by Business Model:

• Recurring D2C Subscriptions
• Corporate & Clinic B2B2C
• Pharmacy Compounding Programs
• Practitioner-Dispensed Protocols

Personalized Nutrition Market segmented by Patient Demographic:

• Adults 18 to 64
• Geriatric 65 and Older
• Pediatric & Adolescent Patients
• Private Insurance & Out-of-Pocket
• Prescription & Clinician-Supervised

Personalized Nutrition Market by Region

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• [1] de Jong, J. C. B. C., Hoevenaars, F. P. M., Peters, L. G. P., Berendsen, C. M. M., Pasman, W. J., Caspers, M. P. M., Dulos, R., & Wopereis, S. (2026, January 5). A Real-Life Digital Intervention for Personalized Nutrition in Adults With Overweight or Obesity: Remote Randomized Controlled Trial. Journal of Medical Internet Research, 28, e73367 (PMC12817035).
• [2] Jeonbuk National University Endocrinology Clinical Trial Group. (2026, July 15). Effect of a Continuous Glucose Monitoring-Guided Personalized Lifestyle Coaching Intervention on Glycemic Outcomes in Type 2 Diabetes. Journal of Korean Academy of Nursing (PubMed PMID 42687658).
• [3] Carbohydrate-Restricted CGM Trial Investigators. (2025, September 15). Effects of Continuous Glucose Monitoring Versus Blood Glucose Monitoring During a Carbohydrate-Restricted Nutrition Intervention: 6-Month Outcomes. Diabetes Care (PubMed PMID 40467033).
• [4] Arshad, M. T., Ali, M. K. M., Maqsood, S., Ikram, A., Ahmed, F., Aljameel, A. I., Al-Farga, A., & Hossain, M. S. (2025, September 26). Personalized Nutrition in the Era of Digital Health: A New Frontier for Managing Diabetes and Obesity. Food Science & Nutrition (PMC12474561).
• [5] Telehealth-Delivered Nutrition Economic Study Group. (2026, August 11). Healthcare Cost Impacts of Telehealth-Delivered Personalized Nutrition Therapy in Metabolic Disease. Diabetes Therapy (PubMed PMID 42579263).
• [6] Liu, X., & Precision Nutrition Research Consortium. (2025, August 20). Integrating Precision Medicine and Digital Health in Personalized Weight Management and Metabolic Nutrition. Nutrients, 17(16), 2695 (PubMed PMID 40871725).
• [7] Rare Disease Telemedicine Nutrition Group. (2025, January 26). Telemedicine for Personalized Nutritional Intervention of Rare Metabolic Diseases: Approaches and Clinical Impact. Nutrients (PubMed PMID 39940313).
• [8] dsm-firmenich. (2025, March 11). The Future of Gut Health: 5 Breakthrough Microbiome Trends From Probiota 2025. dsm-firmenich Health, Nutrition & Care.
• [9] Real-Time Continuous Glucose Monitoring Trial Group. (2025, December 17). A Randomized Controlled Trial of Real-Time Continuous Glucose Monitoring Versus Blinded Monitoring in Metabolic Care. American Journal of Obstetrics and Gynecology (PubMed PMID 41419058).
• [10] Nutrigenomics and Microbiome Metabolic Review Panel. (2026, January 19). Mitigation of Metabolic Diseases Through Personalized Nutrition, Nutrigenomics, and Gut Microbiome Profiling. Nutrients (PubMed PMID 41567168).
• [11] Korean Community Nutrition Behavioral Science Group. (2026, April 30). Life-Course Personalized Nutrition Strategy for Adolescents and Young Adults in Korea Based on a Behavioral Science Model. Korean Journal of Community Nutrition, 31(2), 127 to 139 (PMC13175752).
• [12] UAE Digital Health and Clinical Nutrition Consortium. (2026, April 16). Knowledge, Attitudes, and Clinical Practices Toward Digital Health and Personalized Care in the United Arab Emirates. Healthcare (PubMed PMID 42153067).
• [13] Point-of-Care Metabolic Biosensor Investigators. (2025, July 11). Towards Precision Nutrition: A Novel Smartphone-Connected Biosensor for Point-of-Care Detection of Beta-Hydroxybutyrate in Human Blood and Saliva (Sensors, Vol. 25, Issue 14, 4336). PubMed.
• [14] Bermingham, K. M., Linenberg, I., Polychronova, K., & Berry, S. E. (2025, July 3). Effects of a Personalized Nutrition Program on Cardiometabolic Health: A Randomized Controlled Trial (Nature Medicine, Vol. 30, 1888 to 1897). PubMed.
• [15] University of Vienna Department of Nutritional Sciences. (2026, July 21). Dietary Supplement Use, Biomarker Information Sources, and Perceived Risks in German-Speaking Regions: VedieS Study. Frontiers in Nutrition, 13, 1866907 (PubMed PMID 42553145).
• [16] Pokushalov E et al. (2024, November 25). Biomarker-Guided Dietary Supplementation: A Narrative Review of Precision in Personalized Nutrition.. Nutrients, 16(23), 4033 (PMCID PMC11643751).
• [17] Shen Y et al. (2026, July 1). Quantifying the Contributions of Food, Glucose, Sleep, and Microbiome Data to Personalized Glycemic Response Prediction.. Current developments in nutrition, 10(8), 109429 (PMCID PMC13446328).
• [18] Ladeira, ALA. et al. (2026, July 11). Point-of-care magnesium monitoring in athletes: a physiological framework for exercise-related arrhythmic vulnerability.. European journal of applied physiology, 126(9), 4693-4699 (PMID 42435218).
• [19] dsm-firmenich. (2026, February 20). Science, Research, and Health, Nutrition & Care Innovation Approach: Integrated Annual Report 2025. dsm-firmenich Investor Relations.
• [20] Nestle S.A. (2026, February 19). Full-Year Results 2025: Integrating Nutrition and Nestle Health Science for Category Leadership. Nestle Global Media Center.
• [21] Thorne HealthTech, Inc. (2026, August 10). Thorne Sets a Higher Standard for Science-Backed Wellness With New Creatine Plus Alpha-GPC Research Supporting Mental and Physical Performance. Thorne Press Releases.
• [22] Nestle Health Science. (2025, June 25). Nestle Health Science Launches Dedicated GLP-1 Nutrition Support Platform for Muscle Preservation and Micronutrient Care. Nestle Health Science Newsroom.
• [23] Metabolic Biomarker Longevity Study Group. (2026, October 10). Cellular NAD+ Precursors, Amino Acid Fortification, and Lean Muscle Preservation During Weight Reduction. Nutrients (PubMed PMID 42838587).

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• How large is the personalized nutrition market in 2026 and what is forecast for 2036?
• Which metabolic and diagnostic catalysts support demand for personalized nutrition?
• Why do active custom-dosed supplement packs lead the offering type category?
• Why does blood biomarker and CGM telemetry lead diagnostic input modality?
• How do growth rates differ across South Korea, the UAE, and the USA?
• Which notable companies supply custom premixes, microbiome kits, and D2C packs?
• What limits subscriber retention or reimbursement in the personalized nutrition market?
• What should buyers evaluate before selecting a personalized nutrition platform?